Sparano, Francesco
Cavo, Michele
Niscola, Pasquale
Caravita, Tommaso
Efficace, Fabio
Article History
Received: 28 September 2016
Accepted: 2 March 2018
First Online: 20 March 2018
Compliance with ethical standards
:
: FE: Research funding (Lundbeck, TEVA and Amgen); Consultant/Advisory Role (Bristol-Myers Squibb, Seattle Genetics, TEVA and Incyte)MC: Remuneration (Janssen, Celgene, Amgen, Takeda, Bristol-Myers Squibb), Consultant/Advisory Role (Janssen, Celgene, Amgen, Takeda, Bristol-Myers Squibb)TC: Consultant/Advisory Role (Janssen-Cilag, Celgene, Amgen, Takeda, Bristol-Myers Squibb)The remaining authors have no conflicts of interest.I have full control of all primary data and I agree to allow the journal to review their data if requested.